ArticleHistopathology2026
Intramuscular myxoma with chondroid features: two cases expanding the morphological spectrum.
Article in Histopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIntramuscular myxoma is a benign mesenchymal tumour typically composed of bland spindle to stellate cells in abundant myxoid stroma and usually characterized by GNAS mutations. Chondroid matrix has not been previously reported in intramuscular myxoma.
methodsWe describe two intramuscular myxomas with chondroid-type matrix and review the relevant radiological, histological, immunohistochemical and molecular findings, with emphasis on differential diagnostic considerations.
resultsCase 1 occurred in the triceps of a 64-year-old woman and showed focal cartilaginous differentiation, including chondrocytes within lacunar spaces, in an otherwise classic intramuscular myxoma background. The lesional cells were negative for MUC4, S100, cytokeratin, SMA, desmin, CD34, ERG, STAT6 and EMA, and targeted sequencing detected no pathogenic alteration. Case 2 occurred in the vastus medialis of a 48-year-old woman and showed bland spindle to stellate cells in myxoid to collagenous stroma with foci of chondromyxoid matrix, patchy lacunar-type spaces, and territorial basophilia. The lesional cells were positive for CD34, focally positive for SMA and negative for S100, desmin, cytokeratin and SOX10. Whole transcriptome sequencing detected no gene fusion, and targeted sequencing identified GNAS c.602G>A (p.R201H). Both tumours were deep intramuscular and markedly T2 hyperintense and showed peripheral and septal enhancement on MRI.
conclusionsThese cases expand the morphological spectrum of intramuscular myxoma by documenting chondroid and chondromyxoid matrix, likely representing cartilaginous metaplasia. Awareness of this variant is important to avoid misclassification as other chondromyxoid neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.